Serono Symposia International Foundation adheres to guidelines of the European Accreditation Council for Continuing Medical Education (EACCME), and all other professional organizations, as applicable, which state that programs awarding continuing education credits must be balanced, independent, objective, and scientifically rigorous. Investigative and other uses for pharmaceutical agents, medical devices, and other products (other than those uses indicated in approved product labeling/package insert for the product) may be presented in the program (which may reflect clinical experience, the professional literature or other clinical sources known to the presenter). We ask all presenters to provide participants with information about relationships with pharmaceutical or medical equipment companies that may have relevance to their lectures. This policy is not intended to exclude faculty who have relationships with such companies; it is only intended to inform participants of any potential conflicts so participants may form their own judgments, based on full disclosure of the facts. Further, all opinions and recommendations presented during the program and all program-related materials neither imply an endorsement, nor a recommendation, on the part of Serono Symposia International Foundation. All presentations solely represent the independent views of the presenters/authors.
The following faculty indicated no significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:
K Vandenbroeck
The following faculty provided information regarding significant commercial relationships and/or discussions of investigational or non- EMEA/FDA approved (off-label) uses of drugs:
G Comi - Declared receipt of honoraria or consultation fees from TEVA, Serono Symposia International Foundation and Schering
M Freedman - Declared receipt of grants and contracts from Serono Canada and honoraria or consultation fees from Serono Canada, Bayer, Berlex, Schering and TEVA
G Giovannoni - Declared receipt of grants and contracts from PSP Association Europe, Serono, National MS Society, EU Framework 6, MS Society Great Britain and Northern Ireland. Declared receipt of honoraria and consultation fees from Schering Healthcare, TEVA Pharmaceuticals, Biogen-Idec, Serono, Novartis, Abbott Laboratories
D Miller - Declared receipt of grants and contracts from Biogen Idec, GSK, Schering and honoraria or consultation fees from Biogen Idec, GSK, Schering, UCB Pharma and Wyeth
X Montalban - Declared receipt of grants, contracts, honoraria or consultation fees from Serono, Schering, Biogen-Idec, Novartis, Sanofi-Aventis, Eisai and Almirall
P Rieckmann - Declared honoraria or consultation fees from Serono, Schering and TEVA and to be a CLARITY Advisory Board member. His presentation might include information on RNF (Rebif® New Formulation)
M Sandberg - Declared receipt of honoraria or consultation fees from Active Biotech, Sanofi-Aventis, Schering and Serono. Her presentation might include discussion on intravenous immunoglobulin use in connection with pregnancy and nursing; intravenous immunoglobulins are not registered for the treatment of MS
S Schwid - Declared receipt of grants and contracts from Acorda, Forest, Genentech, Merck, Novartis, Pfizer, Serono and honoraria or consultation fees from Berlex, Biogen, Novartis, Pfizer, Serono and TEVA
